ATAI: Atai Life Sciences N.V. Stock

by  •  • Comments Off on ATAI: Atai Life Sciences N.V. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 239.95
Enterprise Value ($M) 249.19
Book Value ($M) 116.55
Book Value / Share 0.59
Price / Book 2.06
NCAV ($M) 37.29
NCAV / Share 0.19
Price / NCAV 6.43

Profitability (mra)
Return on Invested Capital (ROIC) -1.03
Return on Assets (ROA) -0.55
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 3.21
Current Ratio 3.21

Balance Sheet (mrq) ($M)
Current Assets 80.12
Assets 159.39
Liabilities 42.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.31
Operating Income -102.69
Net Income -149.27

Cash Flow Statement (mra) ($M)
Cash From Operations -82.44
Cash from Investing 59.17
Cash from Financing 5.37

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-14 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 139,123 945,627 14.71
2025-04-10 435,996 1,236,527 35.26
2025-04-09 970,748 2,725,618 35.62
2025-04-08 565,514 1,711,849 33.04
2025-04-07 501,244 1,767,367 28.36

(click for more detail)

Similar Companies
AQST – Aquestive Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc. ATXS – Astria Therapeutics, Inc.
AUPH – Aurinia Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io